Healthcare - Biotechnology - NASDAQ - US
$ 1.38
-13.2 %
$ 190 M
Market Cap
-3.94
P/E
BALANCE SHEET
157 M
ASSETS
8.34 M
LIABILITIES
149 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Compass Therapeutics, Inc.
| Current Assets | 154 M |
| Cash & Short-Term Investments | 152 M |
| Receivables | 0 |
| Other Current Assets | 1.42 M |
| Non-Current Assets | 2.99 M |
| Long-Term Investments | 0 |
| PP&E | 2.67 M |
| Other Non-Current Assets | 320 K |
| Current Liabilities | 7.8 M |
| Accounts Payable | 4.09 M |
| Short-Term Debt | 1.2 M |
| Other Current Liabilities | 2.51 M |
| Non-Current Liabilities | 536 K |
| Long-Term Debt | 536 K |
| Other Non-Current Liabilities | -1 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Mar-2020 | Mar-2019 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 24.2 | 34.9 | 144.5 | 47.1 | 25.3 | 57.5 |
| Short Term Investments | 128.2 | 151.7 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.4 | 8.2 | 2.6 | 3.1 | 0.9 | 1.4 |
| Total Current Assets | 153.9 | 194.8 | 147.1 | 50.2 | 26.2 | 58.9 |
| PP&E | 2.7 | 4.5 | 6.3 | 1.1 | 3.8 | 5.4 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0.3 | 0.3 | 0.3 |
| Other Long Term Assets | 0.3 | 0.3 | 0.3 | 0.3 | 0.1 | 0.1 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 156.9 | 199.6 | 153.8 | 51.9 | 30.4 | 64.6 |
| LIABILITIES | ||||||
| Accounts Payable | 4.1 | 3.4 | 0.9 | 1.1 | 0.6 | 1.7 |
| Short Term Debt | 1.2 | 1.1 | 1.0 | 7.5 | 5.6 | 3.7 |
| Other Current Liabilities | (1.6) | 8.3 | 7.9 | 0.5 | (0.7) | 0.3 |
| Total Current Liabilities | 7.8 | 16.2 | 10.6 | 10.1 | 9.8 | 8.5 |
| Long Term Debt | 0.5 | 1.8 | 3.0 | 1.9 | 9.3 | 11.1 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 1 | 0 | 0 | 0 | 129.9 | 129.9 |
| Total Liabilities | 8.3 | 18.0 | 13.7 | 12.0 | 149.0 | 149.4 |
| EQUITY | ||||||
| Common Stock | 13 K | 13 K | 10 K | 5 K | 3.3 | 2.4 |
| Retained Earnings | (315.3) | (272.8) | (233.6) | (151.4) | (121.9) | (87.2) |
| Other Accumulative Comprehensive Income/Loss | 37 K | (0.3) | 0 | 0 | (3.4) | (4.1) |
| Total Equity | 148.5 | 181.6 | 140.1 | 39.9 | (118.6) | (84.8) |
| Total Liabilities and Equity | 156.9 | 199.6 | 153.8 | 51.9 | 30.4 | 64.6 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 127.0 | 105.2 | 62.9 | 30.8 | 52.1 | 52.1 |